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Introduction
Prenatal cocaine exposure (PCE) is related to subtle cognitive, behavioral and physiological 
differences in infancy, childhood and adolescence. Many well-controlled prospective studies 
report that infants and toddlers exposed to cocaine in utero demonstrate impaired affect 
(Tronick et al. 2005), arousal (Bendersky and Lewis 1998), joint attention, visual 
recognition (Singer et al. 2005), auditory comprehension (Singer et al. 2001) and are at risk 
for delayed mental development (Noland et al. 2005). At school age, PCE is linked to higher 
risk for learning disabilities (Morrow et al. 2006) and to subtle deficits in attention, response 
inhibition (Bandstra et al. 2001; Accornero et al. 2007), impulsivity (Savage et al. 2005), 
language development (Lewis et al. 2011), working memory (Schroder et al. 2004; Mayes et 
al. 2007), planning and set shifting (Warner et al. 2006). Adolescents with PCE demonstrate 
deficits in working memory for words and faces, inhibitory control, and early sensory and 
higher order processing of language stimuli (Betancourt et al. 2011; Bridgett and Mayes 
2011; Landi et al. 2012). Difficulty with emotional/behavioral and physiological self-
regulation is demonstrated in all age groups (Minnes et al. 2005; Tronick et al. 2005; Eiden 
et al. 2009; Chaplin et al. 2010), and adolescents are more likely to use cocaine and other 
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drugs compared with their non-exposed peers (Delaney-Black et al. 2011). Little is known 
about the effects of in utero exposure to cocaine on human early brain development that may 
mediate or contribute to such deficits.
Cocaine acts as a powerful central nervous system stimulant by blocking reuptake of the 
monamines, dopamine, serotonin and norepinephrine, resulting in prolonged, 
supraphysiologic synaptic and extracellular levels (Meyer and Quenzer 2005). During 
critical periods of fetal brain development these neurotransmitters play important roles in 
growth and organization (Whitaker-Azmitia et al. 1996)(25), exerting widespread effects on 
neuronal cell proliferation and differentiation (Lauder 1993; Popolo et al. 2004), migration 
(Vitalis and Parnavelas 2003; Riccio et al. 2012), and dendritic growth (Song et al. 2002; 
Song et al. 2004). When taken by mothers during pregnancy, cocaine and its active 
metabolites easily diffuse through the placenta into fetal circulation, where they cross the 
immature blood-brain barrier (Schenker et al. 1993). Animal research shows that cocaine 
exerts direct pharmacological effects on fetal brain, altering metabolism (Benveniste et al. 
2010), cerebral blood supply, cortical neuron volume and functional characteristics (Ren et 
al. 2004; Stanwood and Levitt 2007; Frankfurt et al. 2011).
Results from neuroimaging studies conducted in late childhood and adolescence suggest that 
PCE may be associated with alterations in brain structure and function that persist into 
adolescence and that may contribute to poorer performance on executive function tasks 
measured at school age and in later life. Findings in preadolescent children include 
significant reductions in corpus callosal area, lesser occipital and parietal gray matter (GM) 
volume, smaller right cerebellar volume (Dow-Edwards et al. 2006) and increased levels of 
creatine in frontal lobe white matter, indicative of abnormal energy metabolism (Smith et al. 
2001). At adolescence, PCE is linked to smaller head circumference, total brain and cortical 
GM volume (Rivkin et al. 2008), reduced frontal and orbital frontal cortical volume 
(Roussotte et al. 2010), reduced global cerebral blood flow, greater GM volume in amygdala 
and reduced GM volume in bilateral caudate (Avants et al. 2007; Rao et al. 2007). 
Functional MRI studies reveal greater resting state connectivity of the default mode network 
(DMN), with impaired ability for prefrontal inhibition of limbic circuitry and less 
deactivation of the DMN during working memory challenge (Li et al. 2009; Li et al. 2011). 
A very few imaging studies of infants with PCE have been reported. Delayed brain 
maturation is suggested by EEG findings of slower auditory brainstem response at birth, and 
reduced inter-hemispheric connectivity at birth and 1 year (Scher et al. 2000; Lester et al. 
2003). Neonatal cranial ultrasounds reveal greater incidence of intracranial hemorrhage in 
infants with ‘heavy’ prenatal cocaine exposure, however infants with less exposure do not 
differ from drug-free infants (Frank et al. 1999). Structural MRI studies of brain 
development in infants with PCE have been limited to a single case study at 11 months 
(Gomez-Anson and Ramsey 1994), and to a group of 8 exposed infants (scanned at .6–12 
months) who were then compared with published norms (Link et al. 1991). To date MRI 
study of neonatal brain structure in infants with PCE compared with drug-free controls 
and/or non-cocaine drug-exposed infants has not been reported.
Notably, the aforementioned cognitive, neurobehavioral and neuroimaging findings are by 
no means unequivocal across a large, decades-long body of research (Roussotte et al. 2010; 
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Dow-Edwards 2011; Coyle 2013). Study is complicated by the fact that prenatal cocaine 
exposure is often comorbid with maternal use of other licit and illicit drugs. To address this, 
most investigations have compared children with in utero exposure to cocaine plus tobacco, 
alcohol and/or marijuana, to children with prenatal exposure to these same drugs but without 
cocaine. Nevertheless some studies report no observable PCE effects (Frank et al. 2001). 
Others reveal independent or interactive effects with nicotine, alcohol, or contextual factors 
(prematurity, gender, maternal care, environmental characteristics (Bandstra et al. 2010; 
Eiden et al. 2011; Irner 2012; Liu et al. 2013). The purpose of the current study was to 
examine the effects of prenatal cocaine exposure on infant brain structure during early 
infancy, at a time more proximal to in utero exposure, and less influenced by the postnatal 
environment. We used structural MRI to examine total and regional gray matter (GM), white 
matter (WM) and cerebrospinal fluid (CSF) brain volumes in 2–6 old week cocaine-exposed 
infants with or without other drug exposures, comparing them to drug-naïve infants, and also 
to infants with similar patterns of polydrug exposure without cocaine.
Materials and Methods
Participants
Infants were part of an ongoing study of the effects of prenatal cocaine exposure on 
biological mechanisms underlying mother-infant interaction and attachment characteristics. 
Here we report results from the first 119 infants to complete the infant MRI protocol. 
Mothers were recruited during pregnancy from local obstetric clinics, health departments, 
and programs for substance abuse treatment of pregnant and postpartum mothers. Infants 
were medically healthy singletons, born at ≥ 36 weeks gestation. The study sample (N=119) 
consisted of 33 cocaine-exposed infants with or without in utero exposure to marijuana, 
alcohol, nicotine, opiates and/or SSRIs (PCE), 40 infants with in utero exposure to these 
same drugs but without cocaine (NCOC), and 46 drug-free controls (CTL). The sample 
included 61 males and 58 females, and maternal report of ethnic composition was 59 White, 
33 African American, 25 Multi-Racial, 2 Other. Drug use status was based on self-report on 
Time Line Follow Back Interview (Sobell and Sobell 1995) conducted at 1 month 
postpartum, response to a questionnaire about maternal substance use done at 3 months, and 
medical record queries of prenatal urine toxicology. If maternal self-report or urine 
toxicology was positive for cocaine use at any time during pregnancy, that mother-infant 
dyad was classified as PCE. This study was approved by the Biomedical Institutional 
Review Board of the University of North Carolina.
MR Image Acquisition
Infants were scanned during sleep without sedation. Infants were first fed and then 
swaddled. Sleeping infants were each was fitted with ear protection. A vacuum-fixation 
device was used to secure head position in the scanner. A nurse monitored each infant by 
sight, touch and by pulse oximetry for heart rate and % oxygen saturation throughout the 
scan. All images were acquired using a 3T MRI scanner. An unavoidable scanner 
replacement occurred during the study, resulting in 94 infants scanned on a 3T head only 
Siemens Allegra and 25 infants scanned on a 3T Siemens Tim Trio (Siemens Medical 
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Solutions, Erlangen, Germany). Both scanners are Food and Drug Administration approved 
for use in all age groups. Adjustment for scanner type was added to all statistical models.
T1-weighted structural pulse sequences were obtained with a 3D magnetization prepared 
rapid gradient echo (MP-RAGE) sequence (repetition Time (TR)=1820 ms, echo time 
(TE)=3.75 ms, inversion time (TI)=1100 ms, flip angle=7°, 144 slices, voxel size: 1 × 1 × 1 
mm). Proton density and T2-weighted images were acquired with turbo spin echo sequence 
(TR=6200ms, TE1=17ms, TE2=116ms, flip angle=150°, 58 slices, voxel size=1.3 × 1.3 × 
1.5 mm).
Image Analysis
Brain tissue and cerebral spinal fluid (CSF) were segmented with an automatic segmentation 
tool specifically designed for the neonatal brain, described previously (Prastawa et al. 2005). 
The segmentation method makes use of dual contrast MRI (T1w, T2w) for optimal 
separation of GM, WM and CSF space and uses a co-registered probabilistic neonatal atlas, 
developed by our group, as a spatial prior (Figure 1A–C). The neonatal population atlas 
includes a lobar parcellation into 16 boxes aligned along the brain hemisphere symmetry 
plane and the AC-PC line (Figure 1D). The choice for a box parcellation versus more 
detailed anatomical lobe parcellation as often applied in adult neuroimaging was motivated 
by the fact that the very dense and compact cortical geometry of the neonatal brain presents 
a challenge for a reproducible and reliable subdivision based on sulcal features. The 
neonatal segmentation tool integrates multimodal T1w/T2w MRI registration, intensity bias 
inhomogeneity correction, tissue segmentation, brain stripping and lobe parcellation into one 
integrated platform, and represents a key instrument that has led to a series of publications 
on neonatal brain growth (Gilmore et al. 2007; Knickmeyer et al. 2008; Gilmore et al. 2010; 
Knickmeyer et al. 2011). Figure 1 displays representative 3-D visualizations of segmented 
WM (1E, red) and GM (1F, green), and of CSF shown on the brain cavity surface (1G, 
blue).
Statistical Analysis
Descriptive statistics for each of the three drug exposure groups (PCE, NCOC, CTL) were 
computed for gestational ages at birth and MRI, birth weight, head circumference, gender, 
race, non-cocaine drug exposures, maternal characteristics, scanner, and brain tissue 
volumes. Groups were compared to determine the extent to which they differed on these 
variables, and how PCE and NCOC groups differed on prenatal non-cocaine drug use. 
Group means were compared with analyses of variance; group proportions were tested with 
the chi-square statistic.
Inferential analyses compared brain volumes for drug group differences using analyses of 
covariance (ANCOVA), including gender, scanner, maternal age, gestational age at MRI 
and birth weight as covariates. All reported p values are from 2-tailed tests. Gender x group 
interactions did not attain statistical significance and were not included in subsequent 
models. The first ANCOVA compared total intracranial volume (ICV). The next set of 
multivariate analyses of covariance (MANCOVA) added ICV as those listed above, and 
tested whether the three groups differed in total segmented tissue volumes (GM, CSF, WM). 
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A top-down testing strategy was employed to control type-1 errors: multivariate 
comparisons of group means were examined first, and if statistically significant, then 
univariate test statistics were examined. If those were significant, then pairwise comparisons 
of the three groups were examined. The next set of analyses tested for group differences in 
within-region comparisons (prefrontal, frontal, parietal, occipital) when group differences 
were obtained in the univariate ANCOVA for a specific segmented tissue type. Repeated 
measures analyses of covariance were used to examine GM and CSF volume in dorsal and 
ventral sub-regions of regions with significant group differences. An adaptive false 
discovery rate (FDR) that computes adjusted p-values (Benjamini, 2000) using an adaptive 
linear step-up method was employed to adjust for multiple comparisons, and was applied to 
each MANCOVA separately.
A set of follow-up sensitivity analyses was conducted to address our concerns that PCE 
mothers have been reported to engage in more prenatal drug use in general than NCOC 
mothers, with the goal of accounting for a possible multiple drug bias in the cocaine-
exposed group. The same set of analyses described above was conducted using only the data 
from infants in the PCE and NCOC groups with in utero exposure to 2 or more drugs, with 
number of different drugs used in pregnancy included as an additional covariate.
Results
Participant characteristics
Drug group differences in participant characteristics are described in Table 1. Head 
circumference and gestational age at MRI visit were similar across groups, however 
cocaine-exposed (PCE) infants had significantly lower birth weights and lesser gestational 
duration compared with drug-free (CTL) and non-cocaine drug exposed (NCOC) infants. 
Maternal education, family income, parity and marital status differed by group. Education 
and income were higher in the CTL group, and they were more likely to be married and 
primiparous compared with PCE and NCOC groups, (p < .01 to .0001), which did not differ 
from one another (all p > .05). Maternal age was significantly lower in the NCOC group 
than PCE and CTL groups. There were no group differences in infant gender or race, and no 
differences between PCE and NCOC groups in the proportion of mothers who reported 
using nicotine, marijuana, alcohol, opiates or SSRIs during pregnancy. Notably, a majority 
of both PCE and NCOC mothers reported prenatal cigarette-smoking (87.88% and 87.50%, 
respectively), with lesser use of other drugs in similar proportions across PCE and NCOC 
groups.
However, groups did differ when more detailed drug use data, as reported on the Time Line 
Follow Back interview (TLFB), were examined. Table 2 provides description of drug use for 
each trimester in PCE and NCOC groups for subjects with complete TLFB data. Mothers in 
the PCE group reported smoking more cigarettes per day, on average, in first and third 
trimesters compared with mothers in the NCOC group.
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Total brain volume differences
Table 3 displays adjusted group means and test statistics from two sets of group 
comparisons of intracranial volume (ICV) and total brain GM, WM and CSF volumes. The 
first ANCOVA analyzed group differences in ICV, which did not differ between drug 
exposure groups (ANCOVA (F(2,113)=2.05, p<.13) after adjusting for scanner, infant 
gender, birth weight, gestational age at MRI, and maternal age. The second set analyzed 
total segmented tissue volumes (GM, WM, CSF) using MANCOVA. This analysis indicated 
reliable group differences, adjusting for ICV, scanner, maternal age, infant gender, birth 
weight and gestational age at MRI (F(4,218)=3.62, p=.0071). Individual ANCOVA’s then 
revealed group differences in GM (F(2,117)=7.46, p<.001) and CSF (F(2,117)=4.74, p<.
011). Pair-wise comparisons, show that the PCE group had smaller mean GM volumes than 
CTL and NCOC groups (−2.6% and −2.0%, respectively), and larger CSF volumes than the 
CTL and NCOC groups (+9.0.% and +6.2%, respectively). All group differences remained 
significant at p < .05 or better after adjusting for multiple comparisons.
Regional brain volume differences
The third set of inferential analyses tested for group differences in GM and CSF in four 
different brain regions to determine whether the observed group differences in these two 
tissue types reflected the posterior-to-anterior gradient for cortical development that has 
been reported previously (Gilmore et al. 2007). MANCOVA’s examined group differences 
in GM and CSF across prefrontal, frontal, parietal and occipital brain regions (depicted in 
Figure 1D). Group means, unadjusted for covariates, as well as standard deviations, 
skewness and kurtosis values, are displayed in Supplemental Table 1 to show that brain 
volumes did not deviate significantly from the normal distribution. Figure 2 displays 
regional group differences, adjusted for covariates. Multivariate tests indicated that the 
magnitude of group differences in GM volumes varied across the four regions (MANCOVA 
group*region F(8,214)=2.18, p<.03). Univariate ANCOVA’s yielded significant group 
differences in prefrontal (F(2,110)=4.02, p=.021) and frontal GM (F(2,110)=3.39, p=.037). 
Infants with PCE had smaller mean prefrontal GM volume than CTL (−7.5%) and NCOC 
(−6.1%) groups, and smaller mean frontal GM volume compared with the CTL (−3.1%) and 
NCOC (−1.9%) groups. A multivariate test of Group*Region was significant for regional 
CSF volumes (F(2,110)=2.26, p=.025). PCE infants had significantly larger CSF volumes in 
prefrontal (F=7.98, p=.0006), frontal (F(2,110)=5.18, p=.0071) and parietal regions 
(F(2,110)=4.12, p=.0188) compared with CTL (+29.7%, +19.3%, +14.5%, respectively) and 
NCOC groups (+17.3%, +13.4%, +11.4%, respectively). Covariate-adjusted mean 
differences are displayed in Supplemental Table 2. Group differences between PCE and 
NCOC in prefrontal GM and in parietal CSF became marginally significant at p < .10 after 
adjustment for multiple comparisons.
Follow-up analyses of brain volumes for infants with more than one drug exposure
Concerns that PCE mothers are often reported to engage in more prenatal drug use than 
NCOC mothers led to a follow-up sensitivity analysis to determine whether differences 
between PCE and NCOC infants were present when we included only mothers who reported 
similar levels of drug use during pregnancy. A total of 31 mothers in the PCE group reported 
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using at least one other drug in addition to cocaine during pregnancy, and 29 NCOC mothers 
endorsed using at least two drugs during pregnancy. These mothers ranged from reporting 
using 2 drugs (32% PCE; 72% NCOC), 3 drugs (26% PCE; 24% NCOC) to 4–5 drugs (42% 
PCE; 4% NCOC). Drug use included nicotine (94% PCE; 93% NCOC); alcohol (32% PCE; 
55% NCOC), marijuana (42% PCE, 55% NCOC); opiates (26% PCE; 14% NCOC), and 
SSRIs (26% PCE; 14% NCOC). On average, the NCOC group reported using fewer 
different drug types during gestation compared with the PCE group based on t-tests that 
accounted for possible differences in variability (number of drugs: PCE M=3.12, SD 1.01; 
NCOC M=2.31, SD=0.54; t(58) =4.25, p<.0001). Therefore the number of drugs used was 
included in statistical models.
Comparisons of brain volumes in these two groups are shown in Table 4. ICV volume did 
not differ between PCE and NCOC groups after adjusting for scanner, infant sex, gestational 
age at MRI, birth weight, maternal age and number of drug types used during pregnancy. 
Differences in total tissue volumes were similar to those observed in the total sample after 
adjusting for the same covariates with the addition of ICV to the model, (multivariate 
F(2,50) = 2.78, p = .072). PCE infants had significantly smaller mean total GM (−2.5%; 
Group F(1,50) = 5.53, p=.023) and non-significantly larger total CSF volume (+7.0%; 
F(1,50)=2.47, p<.13) compared with infants with NCOC exposure. Regional differences in 
GM were similar to results seen in the larger sample. The multivariate test of regional GM 
volume group differences across prefrontal, frontal, parietal and occipital regions was 
suggestive but not significant (GM: F(4,48) = 2.24, p=.079). Compared with the NCOC 
group, the PCE group had significantly smaller GM volume in prefrontal cortex (−8.8%; 
F(1,48)=4.48, p=0.039), while mean GM volumes in frontal, parietal and occipital regions 
did not differ. These analyses provided less support for the widespread group differences in 
regional CSF volume that had been observed in the larger sample. The multivariate test of 
CSF regional volume differences was not significant, (F(4,48)=2.79, p=.10), with larger 
CSF volumes present only in prefrontal cortex in infants with PCE compared with the 
NCOC group (+24%; univariate F(1,48)=4.30, p=.043). Group differences in prefrontal GM 
and CSF were no longer significant after adjustment for multiple comparisons.
Dorsal and ventral GM and CSF volume differences
In brain regions where the PCE group demonstrated smaller GM volumes, group differences 
were further examined separately in dorsal and ventral sub-regions. Covariate-adjusted 
means, per cent differences and univariate ANCOVA F values are reported in Supplemental 
Table 3. In models adjusted for scanner, ICV, birth weight, gestational age at MRI, gender, 
and maternal age, MANCOVA testing of GM volumes across subregions was marginally 
significant (F(16,206) = 1.57, p = .079). Univariate analyses showed that infants with PCE 
had smaller mean GM volumes in the dorsal prefrontal cortex (F = 5.93, p =.0036) 
compared with CTL (−12.1%) and NCOC (−10.4%) groups, and in frontal cortex (F = 4.22, 
p = .0172) compared with the CTL group (−4.8%). Larger CSF volumes (multivariate Group 
F(16,206)=2.29, p=.0041) were revealed in dorsal prefrontal (F=9.85, p=.0001), frontal 
(F=7.35, p=.001) and parietal (F=6.01, p=.033) sub-regions in infants with PCE compared 
with CTL (+34.6%, +32.9%, +21.2%, respectively) and NCOC groups (+26.9%,+23.7%, 
+11.4%, respectively). Greater CSF volumes were also present in ventral prefrontal cortex in 
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infants with PCE compared with the CTL group (+23.6%). Group difference in frontal GM 
between PCE and NCOC groups was no longer significant after adjustment for multiple 
comparisons.
In the sub-sample of participants who used at least two drugs during pregnancy, dorsal and 
ventral prefrontal cortex sub-region differences in prefrontal GM and CSF were compared. 
Significant differences were revealed for GM (multivariate F= 3.39, p=.0415) and CSF 
(multivariate F=4.09, p=.0226) volumes. PCE infants had significantly smaller dorsal 
prefrontal GM (−14%, univariate F=6.70, p=.0125) and larger dorsal prefrontal CSF 
volumes (+32%, univariate F=6.32, p=.0151), while ventral prefrontal GM and CSF 
volumes did not differ between groups.
Discussion
To our knowledge this is the first MRI study of neonatal brain structure comparing 
prenatally cocaine-exposed (PCE) infants to both drug-naive infants (CTL) and also to 
infants exposed to licit and illicit drugs other than cocaine that are commonly used in 
pregnancy (NCOC). Despite comparable head circumference, intracranial volume and 
gestational age at testing, PCE infants had smaller total cortical GM and larger CSF volumes 
compared with both CTL and NCOC infants. Notably, these deficits were seen only in the 
PCE group, while CTL and NCOC groups did not differ from one another. Cocaine-related 
differences in GM were restricted to prefrontal and frontal brain regions, and post hoc 
analyses suggest that these may be driven by group differences in dorsal, as opposed to 
ventral, regions. Cocaine-related differences in CSF were larger, with greater CSF volumes 
evident in prefrontal, frontal and parietal regions in PCE compared with both CTL and 
NCOC groups, albeit with most pronounced differences in dorsal prefrontal cortex. A 
similar pattern of results emerged when subsets of infants with exposure to two or more 
drugs in PCE and NCOC groups were compared, however significant differences in GM and 
CSF were restricted to prefrontal cortex only. These findings suggest that observed 
differences in this region are not due to the higher likelihood of maternal use of multiple 
drugs in the PCE group, and differences remained after adjusting for number of other drugs 
used during pregnancy that may exert teratogenic effects on brain development (Cortese et 
al. 2006; Dwyer et al. 2008; Balaraman et al. 2012).
While the exact mechanisms underlying the observed GM volume differences are unclear, 
our findings lend support to the hypothesis that prenatal cocaine exposure during critical 
periods of growth and organization impairs human brain development resulting in 
significant structural, and possibly functional, differences at birth. Animal research reveals 
direct pharmacological effects of cocaine on fetal brain activity (Benveniste et al. 2010), and 
reduction of cortical neurons that is not related to cocaine-induced malnutrition (Ren et al. 
2004). Fetal exposure is extended due to prolonged fetal, compared with maternal, clearance 
(Dow-Edwards 1990), and is associated with reduction of cortical neurons (Ren et al. 2004), 
changes in the density of dendritic spines in striatal spiny neurons (Frankfurt et al. 2009), 
and alterations in dopamine receptor activity and sub-cellular expression (Stanwood and 
Levitt 2007). Moreover the pattern of smaller GM volumes observed with in utero exposure 
is similar to that reported in adults with chronic cocaine use. Cocaine-dependent adults 
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exhibit GM loss in frontal regions including orbital frontal, dorsal lateral prefrontal cortex, 
inferior, medial and superior frontal gyri and premotor cortex, with greater lifetime exposure 
resulting in greater reductions (Franklin et al. 2002; Sim et al. 2007; Alia-Klein et al. 2011; 
Barros-Loscertales et al. 2011; Ersche et al. 2011; Moreno-Lopez et al. 2012). These deficits 
are accompanied by impairment in cognitive skills including decision-making, memory, 
nonverbal problem solving, response inhibition, impulsivity, spatial processing and reaction 
time tasks (Fein et al. 2002; Lane et al. 2010)(62). Similarly, reductions in GM density 
and/or cortical thickness are reported in frontal, temporal and cingulate cortex in cocaine-
dependent adults, and are linked to poorer performance on decision-making and judgment 
tasks (Matochik et al. 2003; Hanlon et al. 2011). Alternatively, our findings may reflect a 
heritable pattern of structural differences in infants at risk for later drug abuse. Recent 
reports show that drug-free first-degree relatives of stimulant-dependent adults share a 
pattern of decreased GM in insula, post-central and inferior frontal gyrus, and GM 
enlargement in subcortical structures (amygdala, putamen). However, these reports also 
suggest that reduced GM volume in prefrontal cortex is more likely a consequence of drug 
exposure than genetic predisposition (Ersche et al. 2012; Ersche et al. 2012). Finally, the 
lesser GM volume we observed in PCE infants is very likely due, in part, to cocaine-related 
reductions in placental blood flow and gestation duration. Maternal cocaine use during 
pregnancy causes uterine contraction and umbilical artery vasoconstriction, reducing blood 
flow to the placenta and creating fetal hypoxia and impaired growth (Covert et al. 1994). 
PCE infants in the current sample had lower birth weights and were born earlier in gestation 
than CTL and NCOC infants, consistent with other reports (Gouin et al. 2011).
Mechanisms underlying our finding of enlarged CSF volume in infants with PCE, despite 
the fact that lateral ventricle volumes did not differ between groups (data not shown), also 
remain unclear. Enlarged CSF volume has been reported concurrent with WM injury in 
toddlers born prematurely (Tzarouchi et al. 2009). CSF enlargement is also consistent with 
adult cocaine or alcohol abuse and suggestive of response to neuronal injury. Cocaine-
dependent adults exhibit increased cortical CSF volume (Bartzokis et al. 2000). Alcohol-
related GM and WM loss is linked to enhanced CSF volumes, which decrease proportionally 
with longer abstinence (Demirakca et al. 2011). Moreover, enhanced CSF volume is a strong 
predictor of brain atrophy in neurodegenerative diseases in older adults (Fox and Schott 
2004; Squitieri et al. 2009). Animal and in vitro studies indicate that CSF enlargement may 
be a marker of cocaine-induced neuroinflammation characterized by up-regulation of pro-
inflammatory cytokines and chemokines in glial cells, and increased permeability of the 
blood-brain barrier which allows migration of leukocyte, monocyte and cell adhesion 
molecules into the CNS (Gan et al. 1999; Yao et al. 2011).
The study has several limitations. MR scanner differences may have provided non-random 
variability that confounded group differences in brain structure, since more PCE infants 
were scanned with the Trio (52%), while ~85% of CTL and NCOC infants were scanned 
with the Allegra. However, scanner type was included as a covariate in all statistical models. 
We also found that infants with PCE were born, on average, 5.1 – 5.5 days earlier and had 
lower mean birth weights(.75 to .83 pounds less), which may have contributed to differences 
in brain structure. However, although prematurity is related to neural and developmental 
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deficits (de Kieviet et al. 2012), infants in the current sample were all delivered at ≥36 
weeks gestation. Only one NCOC and two PCE infants had birth weights defined as Low 
Birth Weight (< 2500g), and none were classified as Very Low Birth Weight (< 1500g)
(CDC 2009). We attempted to address these differences by controlling for birth weight and 
gestational age at MRI in statistical models, and by scanning all infants at comparable post-
conception ages. Another potential limitation is our lack of information regarding maternal 
health, diet and obstetrical care, therefore we are unable to determine the extent to which 
poor or sub-optimal prenatal care and nutrition contributed to our findings. However we did 
measure SES indicators, which have been related to prenatal care, nutrition and birth 
outcome, and these were higher in drug-free CTL compared with both PCE and NCOC 
groups, which did not differ from one another. Therefore differences in brain structure 
between PCE and NCOC may be less reflective of differences in maternal care, diet and 
health than the comparison of PCE and CTL groups. Finally, consistent with prior reports, 
prenatal cocaine-using mothers in our sample engaged in a heterogeneous pattern of 
polydrug use in addition to cocaine. Since it is neither ethical nor possible to randomize 
human subjects to drug use groups, or to limit drug use to cocaine or any other single drug, 
this heterogeneity is unavoidable and reflects drug use in the community. Mothers in the 
PCE group smoked more cigarettes per day during pregnancy, however in contrast to some 
studies (Singer et al. 2005; Eiden et al. 2011), rates of prenatal use of other drugs (alcohol, 
marijuana, opiates) were not greater in PCE than NCOC groups, and significant differences 
in brain structure were retained after adding the number of other drugs used to statistical 
models.
Based on our current findings, a critical question for future study is whether in utero 
exposure to cocaine interrupts or alters important growth, organization and connectivity to 
the extent that it cannot be completely normalized after birth. Although smaller at birth, 
infants with prenatal cocaine exposure reportedly ‘catch-up’ in physical growth by 6 months 
of age, with no clear or consistent differences from non-exposed children at preschool age, 
even in those with heavy exposure (Lumeng et al. 2007). It remains to be determined 
whether this pattern holds true for brain development. Imaging data from non-exposed 
children born prematurely suggest that prematurity-related deficits in brain structure persist 
and underlie developmental impairments at school age (Lowe et al. 2012; Rogers et al. 
2012), with delay in some, but not all, processes of cortical maturation (Phillips et al. 2011). 
Adolescents with PCE show reductions in frontal cortical volumes, however this finding is 
not consistent across all imaging studies of exposed children and adolescents (Smith et al. 
2001; Dow-Edwards et al. 2006; Avants et al. 2007; Rao et al. 2007; Rivkin et al. 2008; 
Roussotte et al. 2010). The cocaine-related GM deficits we observed appear similar to those 
seen in cocaine-abusing adults, who show partial recovery of brain volume and cognitive 
function with cocaine abstinence including increases in GM density in frontal and temporal 
cortices that are related to better performance on executive function tasks (Hanlon et al. 
2011). However, unlike adult use, in utero exposure occurs during a critical time of 
extraordinary brain development characterized by massive growth, neurogenesis, neuronal 
migration, synaptogenesis and organization of cytoarchitecture (Knowles and Penn 2012). 
These processes lay the foundation for the subsequent dramatic and concurrent development 
of brain structure and function in the months following birth. MRI studies of healthy 
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unexposed infants report that total brain size increases by over 100% in the first 12 months 
(Knickmeyer et al. 2008), reaching approximately 72% of adult size in the first year 
(Gilmore et al. 2007) and 80–90% of adult size by two years of age (Pfefferbaum et al. 
1994). This rapid growth is driven primarily by increases in cortical gray matter, which 
increases, on average, by 108% in the first year, however this growth is quite variable, 
ranging from 62–154%. Findings in healthy neonates and children show that frontal gyrus is 
one of the fastest growing regions of GM growth during this time (Gilmore et al. 2012). 
These anterior brain regions are integral to multiple developing brain networks that are 
fundamentally involved in essential cognitive functions including attention, perception, 
memory, inhibition, as well as development of default mode network activity (Lin et al. 
2008; Gao et al. 2009; Yap et al. 2011). Our data represent only a single time point 
embedded within this rapidly changing period, and do not shed light on whether the cocaine-
related GM and CSF differences may be normalized by an accelerated postnatal pace of 
growth. Moreover, imaging studies in non-exposed children and young adults suggest that 
cognitive deficits are often better related to variations in the rate of change rather than to 
variations in anatomy at any single time point, and that differences in cortical volume may 
not be as meaningfully predictive as other measures including cortical thickness and surface 
area (Raznahan et al. 2011).
Conclusion
We report that neonates with prenatal cocaine exposure had smaller gray matter volumes in 
prefrontal and frontal cortical regions important for later executive functions and inhibitory 
control, and also had CSF enlargement indicative of neuronal abnormality. Based on these 
findings, it is not clear whether the cocaine-related gray matter growth is merely delayed or 
if the trajectory of development may be more permanently altered. It is also unclear from 
our data whether and when CSF enlargement may normalize during early life. It will be 
important to determine whether the observed early GM differences, and the altered timing of 
GM development that may occur with accelerated postnatal growth, are associated with 
aberrations in anatomical and functional connectivity. If so, study of whether such 
aberrations substantively impair cognitive function would be warranted. Future longitudinal 
imaging studies that include measures of anatomical structure, function and connectivity are 
needed to determine how these early differences might influence brain development. 
Incorporation of imaging findings with developmental assessments and careful 
quantification of prenatal exposures, as well as pre- and postnatal environmental risk factors, 
will advance understanding of the effects of cocaine on early brain structure and function, 
and will inform potential early interventions to remediate impairments of brain and 
cognitive development.
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• Prenatal cocaine exposure is linked to reduced neonatal total cortical gray matter
• Prenatal cocaine exposure is linked to enlarged neonatal total CSF volume
• Cocaine-induced GM loss is greatest in neonatal prefrontal cortex
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A–C, Representative subject’s coronal views of T1-weighted (A) and T2-weighted (B) 
neonatal images which have been automatically segmented (C) into CSF (blue), gray matter 
(red) and white matter (green). Right brain is on readers’ left. D, Template of the neonatal 
brain for automatic parcellation into cortical regions (left and right, dorsal and ventral, 
prefrontal (PF), frontal (FR), parietal (PA) and occipital (OC) regions. E–G, 3-D 
visualizations of segmented white matter (E, red) and gray matter (F, green), and of CSF 
shown on the brain cavity surface (G, blue) from the same subject shown in Figure 1A–B.
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Regional gray matter (GM) and cerebral spinal fluid (CSF) volume (mm3) differences 
between cocaine-exposed infants (PCE) compared with (A) drug-free Controls and (B) 
infants with non-cocaine other drug exposures (NCOC). The left column illustrates 
significance maps based on p values of ANCOVA comparisons of GM and CSF parcellation 
volumes depicted in Figure 1F and G. Color scale columns at right depict % difference 
between group means. Greater blue intensity signifies greater increases in tissue volume in 
the Cocaine-exposed group; greater yellow intensity denotes greater deficits in the Cocaine-
exposed group.
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Table 4
Group comparisons of brain volumes (mm3) for infants with in utero exposure to > 2 drugs.
Tissue Type
PCE
Mean (SE) n = 31
NCOC
Mean (SE) n = 29
Univariate
Group F2,527 (p)
PCE vs NCOC % difference
ICVa 486,592 (7,230) 462,907 (8,294) 2.24 (.141) + 4.4
Total Tissue Volumesb
 GM 228,932 (1,448) 234,672 (1615) 5.53 (.023) − 2.5
 CSF 65,562 (1608) 61298 (1794) 2.47 (.122) +7.0
 WM 181,825 (1046) 180,348 (1167) 0.70
Regional GM Volumesb
 Prefrontal 20,170 (547) 22,122 (610) 4.48 (.039)c − 8.8*
 Frontal 39,613 (436) 40,240 (487) b 0.73
 Parietal 56,730 (446) 56,508 (411) 0.09
 Occipital 53,735 (476) 54,909 (531) 2.14
Regional CSF Volumesb
 Prefrontal 9,454 (527) b 7,607 (589) 4.30 (.043)c +24.3*
 Frontal 11,596 (505) 10,614 (563) 1.33
 Parietal 10,066 (333) 9,632 (372) 0.60
 Occipital 5,727 (315) 5,486 (352) 0.21
ICV: intracranial volume; GM: gray matter; WM: white matter; CSF: cerebral spinal fluid; PCE: Prenatal Cocaine Exposure; NCOC: Non-Cocaine 
Drug Exposure;
a
Adjusted for scanner, sex, gestational age at scan, birth weight, maternal age, number of drugs during pregnancy;
b
Adjusted for scanner, ICV, sex, gestational age at scan, birth weight, maternal age, number of drugs during pregnancy;
c
p >.10 after adjustment for multiple comparisons
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